Association of Improved Outcomes and Phosphodiesterase-5 Inhibition During Contemporary LVAD Support: End of the Beginning?

JACC Heart Fail. 2022 Feb;10(2):101-103. doi: 10.1016/j.jchf.2021.10.014.
No abstract available

Keywords: LVAD; death; phosphodiesterase-5; stroke.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Heart Failure* / therapy
  • Heart-Assist Devices*
  • Humans
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Stroke*

Substances

  • Phosphodiesterase 5 Inhibitors
  • Cyclic Nucleotide Phosphodiesterases, Type 5